Portal de Periódicos da CAPES

HEALTH RELATED QUALITY OF LIFE ASSESSMENTS FOR PATIENTS WITH BLADDER CANCER

2004; Lippincott Williams & Wilkins; Volume: 172; Issue: 6 Part 1 Linguagem: Inglês

10.1097/01.ju.0000139445.49500.24

1527-3792

Justin P. Parkinson, Badrinath R. Konety,

Urinary and Genital Oncology Studies

No AccessJournal of UrologyReview Articles1 Dec 2004HEALTH RELATED QUALITY OF LIFE ASSESSMENTS FOR PATIENTS WITH BLADDER CANCER JUSTIN P. PARKINSON and BADRINATH R. KONETY JUSTIN P. PARKINSONJUSTIN P. PARKINSON and BADRINATH R. KONETYBADRINATH R. KONETY View All Author Informationhttps://doi.org/10.1097/01.ju.0000139445.49500.24AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We review the current data regarding the impact of various therapeutic alternatives for bladder cancer on health related (HR) quality of life (QOL). Materials and Methods: A MEDLINE search of the English literature from1966 to November 2003 using the search terms "cystectomy," "intravesical therapy" or "bladder cancer" and quality of life yielded 33 articles. Studies of metastatic disease were excluded. The method of evaluation of quality of life in each article was assessed, particularly the instruments used and the population studied. Results: The majority of these reports (20 of 33) compared the impact of different types of urinary diversion on quality of life. The reports provided conflicting data, with several studies showing no significant difference in overall QOL. Some studies revealed a greater improvement in HRQOL with time following continent diversion. Only 2 reports discussed evaluation of HRQOL during intravesical therapy. Either an established standardized QOL instrument or an internally validated instrument was used in all but 8 of the studies. No reports compared the HRQOL effects of bladder sparing treatments to radical cystectomy. Conclusions: There is no single measure of HRQOL predominantly used in patients with bladder cancer. There is a lack of data comparing HRQOL outcomes in patients receiving bladder sparing therapies versus cystectomy. Development of a universally applicable validated instrument would allow a more effective comparison of HRQOL outcomes in these patients as well as in those with superficial and muscle invasive bladder cancer. References 1 : Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care1995; 33: 828. Google Scholar 2 : The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care1992; 30: 473. Google Scholar 3 : Interday reliability of function assessment for a health status measure. The Quality of Well-Being scale. Med Care1989; 27: 1076. Google Scholar 4 : The Sickness Impact Profile: development and final revision of a health status measure. Med Care1981; 19: 787. Google Scholar 5 : Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract1985; 35: 185. Google Scholar 6 : The CARES: a generic measure of health-related quality of life for patients with cancer. Qual Life Res1992; 1: 19. Google Scholar 7 : The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol1993; 11: 570. Google Scholar 8 : Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol1984; 2: 472. Google Scholar 9 : FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Evanston, Illinois: Evanston Northwestern Healthcare and Northwestern University1997. version 4. Google Scholar 10 : Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol2003; 170: 1926. Link, Google Scholar 11 : The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. Qual Life Res1998; 7: 291. Google Scholar 12 : The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst1993; 85: 365. Google Scholar 13 : Assessing health-related quality of life in patients with genitourinary malignancies. In: Diagnosis and Treatment of Genitourinary Malignancies. Edited by . Boston: Kluwer Academic Publishers1996. Google Scholar 14 : The quality of life during intravesical bacillus Calmette-Guerin therapy. J Urol1996; 155: 1221. Link, Google Scholar 15 : Quality of life in patients undergoing bacillus Calmette-Guerin therapy for superficial bladder cancer. Br J Urol1996; 78: 369. Google Scholar 16 : Life with an ileal conduit in cystectomized bladder cancer patients: expectations and experience. Scand J Urol Nephrol1987; 21: 97. Google Scholar 17 : Psychosocial adjustment and general state of health in patients with ileal conduit urinary diversion. Scand J Urol Nephrol1992; 26: 139. Google Scholar 18 : Quality of life survey of urinary diversion patients: comparison of ileal conduit versus continent Kock ileal reservoirs. J Urol1987; 138: 1386. Link, Google Scholar 19 : Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men. BJU Int2000; 85: 26. Google Scholar 20 : Quality of life after cystectomy and urinary diversion: results of a retrospective interdisciplinary study. J Urol1997; 158: 778. Link, Google Scholar 21 : Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol1995; 75: 200. Google Scholar 22 : Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 survey. Urology2000; 55: 862. Google Scholar 23 : Quality of life in patients having an ileal conduit, continent reservoir or orthotopic neobladder after cystectomy for bladder carcinoma. Int J Urol1999; 6: 393. Google Scholar 24 : A comparison of adjustments to urinary diversions: a pilot study. J Wound Ostomy Continence Nurs1995; 22: 58. Google Scholar 25 : Quality of life and health in patients with urinary diversion: a comparison of incontinent versus continent urinary diversion. Eur Urol1997; 32: 23. Google Scholar 26 : Morbidity and quality of life in patients with orthotopic and heterotopic continent urinary diversion. Urology1998; 51: 51. Google Scholar 27 : Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. Semin Urol Oncol2001; 19: 18. Google Scholar 28 : The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life. Ann Surg Oncol2000; 7: 4. Google Scholar 29 : Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study. Qual Life Res2000; 9: 1. Google Scholar 30 : Quality of life survey of urinary diversion patients: comparison of continent urinary diversion versus ileal conduit. Int J Urol1997; 4: 26. Google Scholar 31 : Can preoperative psychosocial defense strategies, mood and type of lower urinary tract reconstruction predict psychosocial adjustment after cystectomy in patients with bladder cancer?. Br J Urol1998; 82: 348. Google Scholar 32 : Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer1996; 78: 1089. Google Scholar 33 : The quality of life after radical radiotherapy for bladder cancer. Br J Urol1992; 70: 519. Google Scholar 34 : Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol2003; 170: 1772. Link, Google Scholar 35 : Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder placement. BJU Int2002; 89: 10. Google Scholar 36 : When should quality of life be measured after radical cystectomy?. Eur Urol2002; 42: 350. Google Scholar 37 : Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology2002; 60: 62. Google Scholar 38 : Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol2002; 20: 3061. Google Scholar 39 : Effect of ileal conduit on patients' activities following radical cystectomy. Urology1991; 37: 33. Google Scholar 40 : Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral Kock pouch. J Urol1999; 162: 77. Link, Google Scholar 41 : Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol2002; 168: 164. Link, Google Scholar 42 : Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol2002; 168: 168. Link, Google Scholar 43 : The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?. BJU Int2002; 90: 386. Google Scholar From the Departments of Urology and Epidemiology (BRK), University of Iowa, Iowa City, Iowa© 2004 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byRitch C, Cookson M, Chang S, Clark P, Resnick M, Penson D, Smith J, May A, Anderson C, You C, Lee H and Barocas D (2018) Impact of Complications and Hospital-Free Days on Health Related Quality of Life 1 Year after Radical CystectomyJournal of Urology, VOL. 192, NO. 5, (1360-1364), Online publication date: 1-Nov-2014. Volume 172Issue 6 Part 1December 2004Page: 2130-2136 Advertisement Copyright & Permissions© 2004 by American Urological Association, Inc.Keywordstreatment outcomeoutcome assessment (health care)bladder neoplasmsquality of lifeMetricsAuthor Information JUSTIN P. PARKINSON More articles by this author BADRINATH R. KONETY More articles by this author Expand All Advertisement PDF downloadLoading ...